Next Article in Journal
Virus-like Particles Produced in the Baculovirus System Protect Hares from European Brown Hare Syndrome Virus (EBHSV) Infection
Next Article in Special Issue
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults
Previous Article in Journal
An In Vitro Approach to Prime or Boost Human Antigen-Specific CD8+ T Cell Responses: Applications to Vaccine Studies
Previous Article in Special Issue
Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer’s Disease, and the Potential Benefits of Targeted Treatment or Vaccination—A Virological Perspective
 
 
Review

Article Versions Notes

Vaccines 2025, 13(7), 730; https://doi.org/10.3390/vaccines13070730
Action Date Notes Link
article xml file uploaded 4 July 2025 14:30 CEST Original file -
article xml uploaded. 4 July 2025 14:30 CEST Update https://www.mdpi.com/2076-393X/13/7/730/xml
article pdf uploaded. 4 July 2025 14:30 CEST Version of Record https://www.mdpi.com/2076-393X/13/7/730/pdf
article html file updated 4 July 2025 14:33 CEST Original file https://www.mdpi.com/2076-393X/13/7/730/html
Back to TopTop